Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Six

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|January 23, 2025
Human oncostatin M deficiency underlies an inherited severe bone marrow failure syndromeAlexandrine Garrigue, Laëtitia Kermasson, Sandrine Susini, et al.
Genome Medicine|September 29, 2018
T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiencyErik L Clarke, A Jesse Connell, Emmanuelle Six, et al.
Blood|February 11, 2020
Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programsEmmanuelle Six, Agathe Guilloux, Adeline Denis, et al.
Kidney International|September 15, 2022
Human kidney-derived hematopoietic stem cells can support long-term multilineage hematopoiesisSteicy Sobrino, Chrystelle Abdo, Bénédicte Neven, et al.
Cell Reports. Medicine|January 27, 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapySteicy Sobrino, Alessandra Magnani, Michaela Semeraro, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
JAMA|April 22, 2015
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndromeSalima Hacein-Bey Abina, H Bobby Gaspar, Johanna Blondeau, et al.
Nature Communications|April 30, 2024
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCIDDaniela Cesana, Maria Pia Cicalese, Andrea Calabria, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|January 23, 2025
Human oncostatin M deficiency underlies an inherited severe bone marrow failure syndromeAlexandrine Garrigue, Laëtitia Kermasson, Sandrine Susini, et al.
Genome Medicine|September 29, 2018
T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiencyErik L Clarke, A Jesse Connell, Emmanuelle Six, et al.
Blood|February 11, 2020
Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programsEmmanuelle Six, Agathe Guilloux, Adeline Denis, et al.
Kidney International|September 15, 2022
Human kidney-derived hematopoietic stem cells can support long-term multilineage hematopoiesisSteicy Sobrino, Chrystelle Abdo, Bénédicte Neven, et al.
Cell Reports. Medicine|January 27, 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapySteicy Sobrino, Alessandra Magnani, Michaela Semeraro, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
JAMA|April 22, 2015
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndromeSalima Hacein-Bey Abina, H Bobby Gaspar, Johanna Blondeau, et al.
Nature Communications|April 30, 2024
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCIDDaniela Cesana, Maria Pia Cicalese, Andrea Calabria, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Pageof 5